All Categories
Categories
Dr Qasim Rafiq and Dr Rana Khalife discuss cell and gene therapy. Dr Rafiq is an Associate Professor in Cell and Gene Therapy Bioprocess Engineering at UCL, and is also programme director for the Manufacture and Commercialisation of Cell and Gene Therapies MSc at UCL Biochemical Engineering. Dr Khalife is one of the lecturers on the programme.
91
6/16/2021
3 great talks on projects at different stages of development exploring new strategies for tissue repair and regeneration or able to exploit other mechanisms of healing.
Agenda:
Dr Asha Recino (TIN coordinator)- Introduction of Regenerative Medicine TIN
Prof. Julie Daniels (IoO, TIN chair)- Introduction of speakers
Prof. Suwan Jayasinghe (Dept of Mechanical Engineering)- Cell Handling Platforms for Reconstructing Multi-Cellular Three-Dimensional Architectures
Dr Aurora Almadori (Division of Surgery & Interventional Science)- The Use of Human Adipose Derived Stem Cells in Scleroderma
Dr Chara Simitzi (Institute of Materials Discovery)- Modular Bottom-Up Tissue Engineering with Implantable Microcarriers and Mesenchymal Stromal Cells
To keep updated with activities and opportunities from the Regenerative Medicine TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
57
11/27/2020
RegMed TIN Seminar series kicks off with 3 great projects at varied stages of development enabling new therapies for eye & brain disorders.
About this Event
In this seminar series, the Regenerative Medicines TIN will look at innovative technologies involving tissue engineering, cell biology, and materials science for therapeutic applications and will showcase collaborative projects aiming at restoring impaired function of organs in the body.
To keep updated with activities and opportunities from the Regenerative Medicine TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
37
10/1/2020
Alexandra Lubin, Dept of Haematology, UCL Cancer Institute
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Early Careers Network Session
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
635
6/6/2019
Prof Tariq Enver
Professor of Stem Cell Biology
Director, Cancer Institute
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
Cancer evolution: can we beat Nature?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
103
6/3/2019